Skip to main content

Peer Review reports

From: SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?

Original Submission
3 Aug 2022 Submitted Original manuscript
16 Sep 2022 Author responded Author comments - Kato Rans
Resubmission - Version 2
16 Sep 2022 Submitted Manuscript version 2
2 Oct 2022 Reviewed Reviewer Report
7 Oct 2022 Reviewed Reviewer Report
26 Oct 2022 Author responded Author comments - Kato Rans
Resubmission - Version 3
26 Oct 2022 Submitted Manuscript version 3
27 Oct 2022 Reviewed Reviewer Report
6 Nov 2022 Reviewed Reviewer Report
22 Nov 2022 Author responded Author comments - Kato Rans
Resubmission - Version 4
22 Nov 2022 Submitted Manuscript version 4
Publishing
24 Nov 2022 Editorially accepted
12 Dec 2022 Article published 10.1186/s12885-022-10374-0

You can find further information about peer review here.

Back to article page